by Anna Tan | Nov 28, 2018 | Featured Posts
Healthcare reform and improvement has entered exciting times. Medical R&D and health informatics (HIT) are growing at a rapid rate, offering better options to a more curious and proactive generation of consumers. More regulatory bodies and forward-thinking...
by Anna Tan | Nov 19, 2018 | Pharmacy
Today’s healthcare industry is a race between technology, policy, and support, with the endpoint for all of them being a more patient-centered approach. Technological advancements have made precision medicine possible, resulting in an explosion of data and inquiries...
by Anna Tan | Nov 14, 2018 | Pharmacy
Moving Forward with Proper PGx Expectations 2,5Pharmacogenomic (PGx) testing and PGx-based treatments may be all the rage in precision medicine today, but more genetic and pharmacology experts – especially in the areas of cardiology, pain management, and psychiatry –...
by Megan Brown | Nov 7, 2018 | Alerts
A cohort study by the United Kingdom Clinical Research Datalink associated the use of ACEIs with an increased risk of lung cancer. The association elevated among people using ACE Inhibitors for more than five years. The study consisted of 992,061 patients treated with...
by pepidwpblog | Nov 5, 2018 | Press & Media
For Immediate Release: September 15, 2017 — Phoenix, AZ Statement: PEPID, LLC, the leading developer of point-of-care clinical decision support solutions, will be participating in the ASHP Midyear 2018 Clinical Meeting and Exhibition as an exhibitor at booth...
by Anna Tan | Nov 1, 2018 | Pharmacy
Moving Forward with New Provisions The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6), signed on October 24, 2018, addresses the opioid crisis by reducing supply and access while...
by Anna Tan | Oct 8, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
Pharmacogenomics (PGx) is rapidly evolving from being a “luxury” diagnostic test to the healthcare standard millions of patients and providers have been waiting for. Although PGx is a relatively new field, the R&D support and buzz behind it is growing...
by Anna Tan | Oct 1, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
While medical R&D has been making great strides in precision medicine and pharmacogenetics – ultimately tailoring diagnostics and treatments to match individuals on a submolecular level – healthcare providers need to remember that their relationships with their...
by Anna Tan | Aug 3, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care, Uncategorized
August kicks off with World Breastfeeding Week, now on its 27th year since it was first celebrated by the World Alliance for Breastfeeding Action (WABA) in 1992. Every August 1-7, WABA partners with a worldwide network of organizations to encourage breastfeeding,...
by Megan Brown | Jul 16, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
Evidence that Adverse Drug Interactions Occur from Herbal-Drug Interactions and Non-Prescription Drug Interactions. “Natural” is widely perceived by the public to ensure safety. However, studies show drug interactions with active pharmaceutical agents, and...
by Megan Brown | Jul 2, 2018 | Alerts
Another mosquito-borne virus has been confirmed to infect humans, after a report published in June from the peer-reviewed medical journal Clinical Infectious Diseases. Keystone has been known to infect animals since its discovery in Tampa-Bay area in 1964 but has...
by Megan Brown | Jun 22, 2018 | Emergency Medicine, Featured Posts, Nursing, Pharmacy, Primary Care
The World Health Organization has released the 11th edition of the International Classification of Diseases (ICD-11). Here are a few of the notable changes. ICD-11 is completely electronic with 40,600 more codes for injuries, diseases and cause of death than ICD-10....
by Megan Brown | Jun 13, 2018 | Alerts
The Journal of the American Medical Association published a study with evidence to reveal adults taking concurrent medications with the adverse side effect of causing depression have a heightened risk of depressive symptoms. The researchers assessed the prescribed...
by Megan Brown | Jun 11, 2018 | Pharmacy, Primary Care
The first migraine prevention medication was approved by the FDA in May, 2018. Pharmaceutical companies Amgen and Novartis designed the CGRP receptor blocking monthly injection Aimovig (erenumab-aooe) as a game changer for those who suffer from migraines. Aimovig is...
by Megan Brown | Jun 8, 2018 | Alerts
The American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists’ Committees on Pain Medicine and Standards and Practice Parameter have determined a consensus guideline for the...
